Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 143192, 6 pages
http://dx.doi.org/10.1155/2014/143192
Research Article

Alleviation of Plasma Homocysteine Level by Phytoestrogen -Zearalanol Might Be Related to the Reduction of Cystathionine -Synthase Nitration

1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, No. 10 Xitoutiao, You An Men Wai, Beijing 100069, China
2Beijing Key Laboratory of Metabolic Disorders Related Cardiovascular Diseases, No. 10 Xitoutiao, You An Men Wai, Beijing 100069, China
3Department of Pathology, Beijing Luhe Hospital, Capital Medical University, 82 Xinhuanan Road, Tongzhou District, Beijing 101149, China
4Beijing Stomatological Hospital, Capital Medical University, 4 Tiantanxili, Dongcheng District, Beijing 100050, China

Received 2 January 2014; Revised 24 February 2014; Accepted 24 February 2014; Published 24 March 2014

Academic Editor: Kota V. Ramana

Copyright © 2014 Hui Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Homocysteine Study Collaboration, “Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis,” The Journal of the American Medical Association, vol. 288, no. 16, pp. 2015–2022, 2002. View at Google Scholar
  2. M. Gol, P. Akan, E. Dogan, C. Karas, U. Saygili, and C. Posaci, “Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels,” Maturitas, vol. 53, no. 3, pp. 252–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Schindler, “Progestogen deficiency and endometrial cancer risk,” Maturitas, vol. 62, no. 4, pp. 334–337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Opatrny, S. Dell'Aniello, S. Assouline, and S. Suissa, “Hormone replacement therapy use and variations in the risk of breast cancer,” BJOG, vol. 115, no. 2, pp. 169–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Kerlikowske, D. L. Miglioretti, R. Ballard-Barbash et al., “Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population,” Journal of Clinical Oncology, vol. 21, no. 23, pp. 4314–4321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. E. Walker, M. R. Adams, A. A. Franke, and T. C. Register, “Effects of dietary soy protein on iliac and carotid artery atherosclerosis and gene expression in male monkeys,” Atherosclerosis, vol. 196, no. 1, pp. 106–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Dai, J. Duan, Y. Lu et al., “α-zearalanol, a phytoestrogen for cardiovascular therapy,” Endocrine, vol. 25, no. 2, pp. 117–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Stob, R. Baldwin, J. Tuite, F. Andrews, and K. Gillette, “Isolation of an anabolic, uterotrophic compound from corn infected with Gibberella zeae,” Nature, vol. 196, no. 4861, Article ID 1318, 1962. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Xu, J. Duan, S. Dai, Y. Wu, R. Sun, and J. Ren, “α-zearalanol attenuates oxLDL-induced ET-1 gene expression, ET-1 secretion and redox-sensitive intracellular signaling activation in human umbilical vein endothelial cells,” Toxicology Letters, vol. 179, no. 3, pp. 163–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Liu, D. D. Hou, Q. Zhao et al., “Phytoestrogen α-zearalanol attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells,” BioMed Research International, vol. 2013, Article ID 813450, 12 pages, 2013. View at Publisher · View at Google Scholar
  11. W. Wang, D. J. Jiang, Y. F. Zhu, W. Liu, J. H. Duan, and S. L. Dai, “Relaxing effects of phytoestrogen α-zearalanol on rat thoracic aorta rings in vitro,” Chinese Journal of Physiology, vol. 52, no. 2, pp. 99–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Dai, J. Duan, Y. Lu et al., “Phytoestrogen α-zearalanol inhibits atherogenesis and improves lipid profile in ovariectomized cholesterol-fed rabbits,” Endocrine, vol. 25, no. 2, pp. 121–129, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Wang, G. J. Zhu, and S. Y. Zu, “Effects on 17β-estradiol and phytoestrogen α-zearalanol on tissue factor in plasma of ovariectomized rats and HUVECs,” Chinese Journal of Physiology, vol. 47, no. 2, pp. 67–72, 2004. View at Google Scholar · View at Scopus
  14. P. P. Zhen, J. H. Duan, Q. Zhao et al., “Phytoestrogen α-zearalanol improves vascular function in ovariectomized hyperhomocysteinemic rats,” Atherosclerosis, vol. 215, no. 2, pp. 309–315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Celano, M. Gil, S. Carballal et al., “Inactivation of cystathionine β-synthase with peroxynitrite,” Archives of Biochemistry and Biophysics, vol. 491, no. 1-2, pp. 96–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Castro, I. Rivera, H. Blom, C. Jakobs, and I. T. de Almeida, “Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview,” Journal of Inherited Metabolic Disease, vol. 29, no. 1, pp. 3–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. H. Bønaa, I. Njølstad, P. M. Ueland et al., “Homocysteine lowering and cardiovascular events after acute myocardial infarction,” The New England Journal of Medicine, vol. 354, no. 15, pp. 1578–1588, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Ebbing, Ø. Bleie, P. M. Ueland et al., “Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial,” The Journal of the American Medical Association, vol. 300, no. 7, pp. 795–804, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Barroso, M. S. Rocha, R. Esse et al., “Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells,” Amino Acids, vol. 42, no. 5, pp. 1903–1911, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Jin, R. B. Caldwell, T. Li-Masters, and R. W. Caldwell, “Homocysteine induces endothelial dysfunction via inhibition of arginine transport,” Journal of Physiology and Pharmacology, vol. 58, no. 2, pp. 191–206, 2007. View at Google Scholar · View at Scopus
  21. C. Szabó, H. Ischiropoulos, and R. Radi, “Peroxynitrite: biochemistry, pathophysiology and development of therapeutics,” Nature Reviews Drug Discovery, vol. 6, no. 8, pp. 662–680, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus